GEORGE C. SCHUSSLER, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
To the Editor: In the editorial note on the measurement of parathyroid hormone (PTH) (1) Dr. Reiss points out that immunoassayable parathyroid hormone has been found in the serum of hypercalcemic patients with nonparathyroid tumors. In the study by Berson and Yalow (2), which is referred to, the immunoassays were actually done on sera from normocalcemic patients with bronchogenic carcinoma. Many of these patients had higher than normal plasma concentrations of immunoassayable PTH. The lack of hypercalcemia in these patients could be interpreted as a negative endogenous bioassay and may reflect on the adequacy of the immunoassay as a measure
SCHUSSLER GC. HYPERCALCEMIA OF CANCER. Ann Intern Med. ;70:1280–1281. doi: 10.7326/0003-4819-70-6-1280_2
Download citation file:
Published: Ann Intern Med. 1969;70(6):1280-1281.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use